anonymous
Guest
anonymous
Guest
Its not just the medical. Look at the commercial. They have something good with adagrasib. But they decided to bring on a piss poor team based on zero reference checking.
short this while its over a hundred. It will be 70-80 by March-April. By Q4 it will be in the 30's. valuation is bloated like a tick on a elephants A$$